Teleflex Incorporated (NYSE:TFX) Given Consensus Recommendation of “Hold” by Brokerages

Teleflex Incorporated (NYSE:TFX) has earned an average recommendation of “Hold” from the nine brokerages that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $144.00.

TFX has been the topic of a number of research analyst reports. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a report on Monday, April 13th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Needham & Company LLC lifted their target price on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Mizuho set a $140.00 price target on Teleflex in a research report on Friday, May 8th. Finally, Truist Financial reissued a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of TFX. Ruffer LLP acquired a new position in shares of Teleflex during the 4th quarter valued at $5,154,000. Waterfront Wealth Inc. acquired a new stake in Teleflex in the 4th quarter valued at $2,050,000. Eos Management L.P. purchased a new position in Teleflex in the fourth quarter valued at about $3,763,000. Capital International Investors purchased a new position in Teleflex in the third quarter valued at about $44,851,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in shares of Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock worth $3,395,000 after purchasing an additional 19,327 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Trading Down 0.3%

NYSE TFX opened at $129.84 on Friday. Teleflex has a 12 month low of $100.18 and a 12 month high of $139.67. The company has a 50-day moving average of $120.74 and a 200-day moving average of $116.77. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The company has a market cap of $5.75 billion, a P/E ratio of -5.69, a P/E/G ratio of 0.97 and a beta of 0.82.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same period last year, the company earned $1.44 earnings per share. The company’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts predict that Teleflex will post 6.7 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.